Selected research
Market Outlook & Growth Opportunities
Global α-Bisabolol Market Outlook and Growth Opportunities 2026
Market perspective
The global α-Bisabolol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for α-Bisabolol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for α-Bisabolol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for α-Bisabolol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the α-Bisabolol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the α-Bisabolol market include Beijing Brilliance Bio, BASF Care Creations, Vantage Specialty Ingredients, Vanderbilt Minerals, LLC, TRI-K Industries, Inc., Symrise, Spec-Chem Industry Inc., Sasol Performance Chemicals and Kobo Products, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global α-Bisabolol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of α-Bisabolol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents α-Bisabolol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the α-Bisabolol market size, projected growth trends, production technologies, key applications, and end-use industries.
α-Bisabolol Segment by Company
Beijing Brilliance Bio
BASF Care Creations
Vantage Specialty Ingredients
Vanderbilt Minerals, LLC
TRI-K Industries, Inc.
Symrise
Spec-Chem Industry Inc.
Sasol Performance Chemicals
Kobo Products, Inc.
HallStar Company
Extracts & Ingredients Ltd.
EMD Chemicals Inc. / Rona
DKSH North America, Inc.
Biocosmethic
Atina
α-Bisabolol Segment by Type
Purity:Above 75.0%
Purity:75.0%
α-Bisabolol Segment by Application
Oral Hygiene Products
Cosmetics
Skin Care Products
α-Bisabolol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global α-Bisabolol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions α-Bisabolol market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify α-Bisabolol significant trends, drivers, influence factors in global and regions.
6. To analyze α-Bisabolol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global α-Bisabolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of α-Bisabolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of α-Bisabolol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the α-Bisabolol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global α-Bisabolol industry.
Chapter 3: Detailed analysis of α-Bisabolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of α-Bisabolol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of α-Bisabolol in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity:Above 75.0%
- Purity:75.0%
Applications
- Oral Hygiene Products
- Cosmetics
- Skin Care Products
Companies covered
- Beijing Brilliance Bio
- BASF Care Creations
- Vantage Specialty Ingredients
- Vanderbilt Minerals, LLC
- TRI-K Industries, Inc.
- Symrise
- Spec-Chem Industry Inc.
- Sasol Performance Chemicals
- Kobo Products, Inc.
- HallStar Company
- Extracts & Ingredients Ltd.
- EMD Chemicals Inc. / Rona
- DKSH North America, Inc.
- Biocosmethic
- Atina
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global α-Bisabolol Sales Value (2021-2032)
- 1.2.2 Global α-Bisabolol Sales Volume (2021-2032)
- 1.2.3 Global α-Bisabolol Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 α-Bisabolol Market Dynamics
- 2.1 α-Bisabolol Industry Trends
- 2.2 α-Bisabolol Industry Drivers
- 2.3 α-Bisabolol Industry Opportunities and Challenges
- 2.4 α-Bisabolol Industry Restraints
3 α-Bisabolol Market by Company
- 3.1 Global α-Bisabolol Company Revenue Ranking in 2025
- 3.2 Global α-Bisabolol Revenue by Company (2021-2026)
- 3.3 Global α-Bisabolol Sales Volume by Company (2021-2026)
- 3.4 Global α-Bisabolol Average Price by Company (2021-2026)
- 3.5 Global α-Bisabolol Company Ranking (2024-2026)
- 3.6 Global α-Bisabolol Company Manufacturing Base and Headquarters
- 3.7 Global α-Bisabolol Company Product Type and Application
- 3.8 Global α-Bisabolol Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global α-Bisabolol Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 α-Bisabolol Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 α-Bisabolol Market by Type
- 4.1 α-Bisabolol Type Introduction
- 4.1.1 Purity:Above 75.0%
- 4.1.2 Purity:75.0%
- 4.2 Global α-Bisabolol Sales Volume by Type
- 4.2.1 Global α-Bisabolol Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global α-Bisabolol Sales Volume by Type (2021-2032)
- 4.2.3 Global α-Bisabolol Sales Volume Share by Type (2021-2032)
- 4.3 Global α-Bisabolol Sales Value by Type
- 4.3.1 Global α-Bisabolol Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global α-Bisabolol Sales Value by Type (2021-2032)
- 4.3.3 Global α-Bisabolol Sales Value Share by Type (2021-2032)
5 α-Bisabolol Market by Application
- 5.1 α-Bisabolol Application Introduction
- 5.1.1 Oral Hygiene Products
- 5.1.2 Cosmetics
- 5.1.3 Skin Care Products
- 5.2 Global α-Bisabolol Sales Volume by Application
- 5.2.1 Global α-Bisabolol Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global α-Bisabolol Sales Volume by Application (2021-2032)
- 5.2.3 Global α-Bisabolol Sales Volume Share by Application (2021-2032)
- 5.3 Global α-Bisabolol Sales Value by Application
- 5.3.1 Global α-Bisabolol Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global α-Bisabolol Sales Value by Application (2021-2032)
- 5.3.3 Global α-Bisabolol Sales Value Share by Application (2021-2032)
6 α-Bisabolol Regional Sales and Value Analysis
- 6.1 Global α-Bisabolol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global α-Bisabolol Sales by Region (2021-2032)
- 6.2.1 Global α-Bisabolol Sales by Region: 2021-2026
- 6.2.2 Global α-Bisabolol Sales by Region (2027-2032)
- 6.3 Global α-Bisabolol Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global α-Bisabolol Sales Value by Region (2021-2032)
- 6.4.1 Global α-Bisabolol Sales Value by Region: 2021-2026
- 6.4.2 Global α-Bisabolol Sales Value by Region (2027-2032)
- 6.5 Global α-Bisabolol Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America α-Bisabolol Sales Value (2021-2032)
- 6.6.2 North America α-Bisabolol Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe α-Bisabolol Sales Value (2021-2032)
- 6.7.2 Europe α-Bisabolol Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific α-Bisabolol Sales Value (2021-2032)
- 6.8.2 Asia-Pacific α-Bisabolol Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America α-Bisabolol Sales Value (2021-2032)
- 6.9.2 South America α-Bisabolol Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa α-Bisabolol Sales Value (2021-2032)
- 6.10.2 Middle East & Africa α-Bisabolol Sales Value Share by Country, 2025 VS 2032
7 α-Bisabolol Country-level Sales and Value Analysis
- 7.1 Global α-Bisabolol Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global α-Bisabolol Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global α-Bisabolol Sales by Country (2021-2032)
- 7.3.1 Global α-Bisabolol Sales by Country (2021-2026)
- 7.3.2 Global α-Bisabolol Sales by Country (2027-2032)
- 7.4 Global α-Bisabolol Sales Value by Country (2021-2032)
- 7.4.1 Global α-Bisabolol Sales Value by Country (2021-2026)
- 7.4.2 Global α-Bisabolol Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.5.2 USA α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.9.2 France α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.16.2 China α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.19.2 India α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran α-Bisabolol Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt α-Bisabolol Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt α-Bisabolol Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt α-Bisabolol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Beijing Brilliance Bio
- 8.1.1 Beijing Brilliance Bio Company Information
- 8.1.2 Beijing Brilliance Bio Business Overview
- 8.1.3 Beijing Brilliance Bio α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Beijing Brilliance Bio α-Bisabolol Product Portfolio
- 8.1.5 Beijing Brilliance Bio Recent Developments
- 8.2 BASF Care Creations
- 8.2.1 BASF Care Creations Company Information
- 8.2.2 BASF Care Creations Business Overview
- 8.2.3 BASF Care Creations α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.2.4 BASF Care Creations α-Bisabolol Product Portfolio
- 8.2.5 BASF Care Creations Recent Developments
- 8.3 Vantage Specialty Ingredients
- 8.3.1 Vantage Specialty Ingredients Company Information
- 8.3.2 Vantage Specialty Ingredients Business Overview
- 8.3.3 Vantage Specialty Ingredients α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Vantage Specialty Ingredients α-Bisabolol Product Portfolio
- 8.3.5 Vantage Specialty Ingredients Recent Developments
- 8.4 Vanderbilt Minerals, LLC
- 8.4.1 Vanderbilt Minerals, LLC Company Information
- 8.4.2 Vanderbilt Minerals, LLC Business Overview
- 8.4.3 Vanderbilt Minerals, LLC α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Vanderbilt Minerals, LLC α-Bisabolol Product Portfolio
- 8.4.5 Vanderbilt Minerals, LLC Recent Developments
- 8.5 TRI-K Industries, Inc.
- 8.5.1 TRI-K Industries, Inc. Company Information
- 8.5.2 TRI-K Industries, Inc. Business Overview
- 8.5.3 TRI-K Industries, Inc. α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.5.4 TRI-K Industries, Inc. α-Bisabolol Product Portfolio
- 8.5.5 TRI-K Industries, Inc. Recent Developments
- 8.6 Symrise
- 8.6.1 Symrise Company Information
- 8.6.2 Symrise Business Overview
- 8.6.3 Symrise α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Symrise α-Bisabolol Product Portfolio
- 8.6.5 Symrise Recent Developments
- 8.7 Spec-Chem Industry Inc.
- 8.7.1 Spec-Chem Industry Inc. Company Information
- 8.7.2 Spec-Chem Industry Inc. Business Overview
- 8.7.3 Spec-Chem Industry Inc. α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Spec-Chem Industry Inc. α-Bisabolol Product Portfolio
- 8.7.5 Spec-Chem Industry Inc. Recent Developments
- 8.8 Sasol Performance Chemicals
- 8.8.1 Sasol Performance Chemicals Company Information
- 8.8.2 Sasol Performance Chemicals Business Overview
- 8.8.3 Sasol Performance Chemicals α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Sasol Performance Chemicals α-Bisabolol Product Portfolio
- 8.8.5 Sasol Performance Chemicals Recent Developments
- 8.9 Kobo Products, Inc.
- 8.9.1 Kobo Products, Inc. Company Information
- 8.9.2 Kobo Products, Inc. Business Overview
- 8.9.3 Kobo Products, Inc. α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Kobo Products, Inc. α-Bisabolol Product Portfolio
- 8.9.5 Kobo Products, Inc. Recent Developments
- 8.10 HallStar Company
- 8.10.1 HallStar Company Company Information
- 8.10.2 HallStar Company Business Overview
- 8.10.3 HallStar Company α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.10.4 HallStar Company α-Bisabolol Product Portfolio
- 8.10.5 HallStar Company Recent Developments
- 8.11 Extracts & Ingredients Ltd.
- 8.11.1 Extracts & Ingredients Ltd. Company Information
- 8.11.2 Extracts & Ingredients Ltd. Business Overview
- 8.11.3 Extracts & Ingredients Ltd. α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Extracts & Ingredients Ltd. α-Bisabolol Product Portfolio
- 8.11.5 Extracts & Ingredients Ltd. Recent Developments
- 8.12 EMD Chemicals Inc. / Rona
- 8.12.1 EMD Chemicals Inc. / Rona Company Information
- 8.12.2 EMD Chemicals Inc. / Rona Business Overview
- 8.12.3 EMD Chemicals Inc. / Rona α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.12.4 EMD Chemicals Inc. / Rona α-Bisabolol Product Portfolio
- 8.12.5 EMD Chemicals Inc. / Rona Recent Developments
- 8.13 DKSH North America, Inc.
- 8.13.1 DKSH North America, Inc. Company Information
- 8.13.2 DKSH North America, Inc. Business Overview
- 8.13.3 DKSH North America, Inc. α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.13.4 DKSH North America, Inc. α-Bisabolol Product Portfolio
- 8.13.5 DKSH North America, Inc. Recent Developments
- 8.14 Biocosmethic
- 8.14.1 Biocosmethic Company Information
- 8.14.2 Biocosmethic Business Overview
- 8.14.3 Biocosmethic α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Biocosmethic α-Bisabolol Product Portfolio
- 8.14.5 Biocosmethic Recent Developments
- 8.15 Atina
- 8.15.1 Atina Company Information
- 8.15.2 Atina Business Overview
- 8.15.3 Atina α-Bisabolol Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Atina α-Bisabolol Product Portfolio
- 8.15.5 Atina Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 α-Bisabolol Value Chain Analysis
- 9.1.1 α-Bisabolol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 α-Bisabolol Sales Mode & Process
- 9.2 α-Bisabolol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 α-Bisabolol Distributors
- 9.2.3 α-Bisabolol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst